Wattana Karnpaet PCLBKK:NEW 87 PB Ratio is 1.52 as of Jul. 05, 2026, which is 8% below its 10-year median of 1.66. GuruFocus rates BKK:NEW with a GF Score™ of 87/100 and a GF Value™ of ฿97.11 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 607 Healthcare Providers & Services companies, Wattana Karnpaet PCL ranks better than 61.45% on this metric.
Wattana Karnpaet PCL stock PB Ratio (=1.52) is close to 1-year low of 1.52.
The historical rank and industry rank for Wattana Karnpaet PCL's PB Ratio or its related term are showing as below:
BKK:NEW'
s PB Ratio Range Over the Past 10 Years
Min: 1.13 Med: 1.66 Max: 3.44
Current: 1.52
During the past 13 years, Wattana Karnpaet PCL's highest PB Ratio was 3.44. The lowest was 1.13. And the median was 1.66.
BKK:NEW's PB Ratio is ranked better than 61.45% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 2.02
vs BKK:NEW: 1.52
During the past 12 months, Wattana Karnpaet PCL's average Book Value Per Share Growth Rate was 4.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 3.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 8.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 5.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Wattana Karnpaet PCL was 57.90% per year. The lowest was -13.50% per year. And the median was 2.65% per year.
Back to Basics: PB Ratio
Wattana Karnpaet PCL (BKK:NEW) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Wattana Karnpaet PCL PB Ratio Related Terms
Wattana Karnpaet PCL PB Ratio Historical Data
* Premium members only.
The historical data trend for Wattana Karnpaet PCL's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Wattana Karnpaet PCL's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wattana Karnpaet PCL PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Wattana Karnpaet PCL's PB Ratio distribution charts can be found below:
* The bar in red indicates where Wattana Karnpaet PCL's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Wattana Karnpaet PCL (BKK:NEW) has a PB Ratio of 1.52 as of Jul. 05, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Wattana Karnpaet PCL and its competitors. This is near median its historical median of 1.66. Over the past decade, Wattana Karnpaet PCL's PB Ratio has ranged from 1.13 to 3.44. According to the industry distribution chart, Wattana Karnpaet PCL ranks #234 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 38.6%.
Is Wattana Karnpaet PCL's PB Ratio too high?
Wattana Karnpaet PCL's current PB Ratio of 1.52 is near median its 10-year median of 1.66. Over the past 10 years, this metric has ranged from a low of 1.13 to a high of 3.44. The Healthcare Providers & Services industry median PB Ratio is 2.02. Wattana Karnpaet PCL's value of 1.52 is 24.8% below this industry median. Based on the distribution chart, Wattana Karnpaet PCL ranks #234 out of 607 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Wattana Karnpaet PCL has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Wattana Karnpaet PCL's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Wattana Karnpaet PCL ranks #234 out of 607 companies for PB Ratio. This puts Wattana Karnpaet PCL in the upper half of its industry. The industry median PB Ratio is 2.02. Wattana Karnpaet PCL's value of 1.52 is 24.8% below this benchmark. Historically, Wattana Karnpaet PCL's own PB Ratio has ranged from 1.13 to 3.44 over the past decade. While the company's 10-year median is 1.66 vs. the industry median of 2.02, Wattana Karnpaet PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.02, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wattana Karnpaet PCL's current PB Ratio of 1.52 is 24.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Wattana Karnpaet PCL and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wattana Karnpaet PCL's current PB Ratio is 1.52, which is near median its own 10-year median of 1.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wattana Karnpaet PCL stock overvalued right now?
Based on GuruFocus' analysis, Wattana Karnpaet PCL (BKK:NEW) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿97.11, compared to a current price of ฿80.50 — trading 17.1% below its estimated fair value. The current PB Ratio is 1.52, which is near median its 10-year median of 1.66 and 24.8% below the Healthcare Providers & Services industry median of 2.02. Wattana Karnpaet PCL's overall GF Score™ is 87/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Wattana Karnpaet PCL (BKK:NEW), the current PB Ratio is 1.52 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wattana Karnpaet PCL (BKK:NEW) Overvalued in 2026?
Based on GuruFocus' analysis, Wattana Karnpaet PCL stock appears to be undervalued.
The current stock price of ฿80.50 is trading 17.1% below its estimated GF Value™ of ฿97.11.
GuruFocus considers Wattana Karnpaet PCL to be Modestly Undervalued.
Key valuation signals for BKK:NEW:
PB Ratio: 1.52 (near median its 10-year median of 1.66)
GF Value™: ฿97.11 vs. price of ฿80.50 (17.1% below fair value)
Industry Position: 24.8% below the Healthcare Providers & Services median (#234 of 607)
No single metric tells the full story. See the BKK:NEW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wattana Karnpaet PCL is engaged in the operation of a hospital under the name North Eastern Wattana Hospital. It has a single segment of operation, namely the hospital and medical trading business. The company earns revenue from hospital, revenue from sales of medicines, and revenue from hospital rooms, which are derived from the provision of services to various types and a large number of customers. Geographically, the company's operations are carried out in Thailand.
87GF Score
Get the complete analysis for BKK:NEW
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:NEW has been successfully added to your 
